Considerations on Integrating Prostate-Specific Membrane Antigen Positron Emission Tomography Imaging Into Clinical Prostate Cancer Trials by National Clinical Trials Network Cooperative Groups.
Schöder H, Hope TA, Knopp M, Kelly WK, Michalski JM, Lerner SP, Tawab-Amiri A, Mann BS, Lin DW, Yu EY, Chen RC, Beach GC, Reeves SA, Shankar LK. Considerations on Integrating Prostate-Specific Membrane Antigen Positron Emission Tomography Imaging Into Clinical Prostate Cancer Trials by National Clinical Trials Network Cooperative Groups. J Clin Oncol. 2022 Jan 11; JCO2102440.